Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ebony Hoskins"'
Publikováno v:
Gynecologic Oncology Reports, Vol 54, Iss , Pp 101422- (2024)
Externí odkaz:
https://doaj.org/article/8828c32aa68940c691375a6d1670fcef
Publikováno v:
Gynecologic Oncology. 166:S12-S13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb7d40e40dac8cf2461ca82cc403a22c
https://doi.org/10.1016/s0090-8258(22)01234-3
https://doi.org/10.1016/s0090-8258(22)01234-3
Autor:
Jasmine J. Han, Ebony Hoskins, Wafic Elmasri, Ben Davidson, Stephen M. Hewitt, Jaime Rodriguez-Canales, Elise C. Kohn, Shing Han
Publikováno v:
Gynecologic oncology. 122(3)
Secretory leukocyte protease inhibitor (SLPI) is amplified in serous ovarian cancer. We have dissected its function, showing it is a survival factor for ovarian cancer and promotes tumorigenesis and paclitaxel-resistance. We hypothesized that the pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07d3084a7506ed34bc6205cf5cd9ee30
https://pubmed.ncbi.nlm.nih.gov/21676452
https://pubmed.ncbi.nlm.nih.gov/21676452
Publikováno v:
Cancer treatment and research. 149
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::784691cae75ae01c4ee1c4eb1cf9c818
https://pubmed.ncbi.nlm.nih.gov/19763442
https://pubmed.ncbi.nlm.nih.gov/19763442
Publikováno v:
Vrije Universiteit Brussel
The alarm anti-protease secretory leukocyte protease inhibitor (SLPI) is frequently overexpressed in ovarian cancer cells and has been proposed for inclusion in biomarker panels but function remains unclear. We hypothesized that SLPI overexpression p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28010258cfbe7c9a354e4145ab602141
https://biblio.vub.ac.be/vubir/overexpression-of-protease-inhibitordead-secretory-leukocyte-protease-inhibitor-causes-more-aggressive-ovarian-cancer-in-vitro-and-in-vivo(39c8711a-51df-40f5-aabe-e3720592cecf).html
https://biblio.vub.ac.be/vubir/overexpression-of-protease-inhibitordead-secretory-leukocyte-protease-inhibitor-causes-more-aggressive-ovarian-cancer-in-vitro-and-in-vivo(39c8711a-51df-40f5-aabe-e3720592cecf).html
Publikováno v:
Cancer Treatment and Research ISBN: 9780387980935
Epithelial ovarian cancer is the most common cause of death among gynecologic malignancies in the Western world. The disease presents late in more than two thirds of patients with spread in the peritoneal cavity on surfaces, intraparenchymal metastas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec6e7211976419b960ef1040c4e0f2b5
https://doi.org/10.1007/978-0-387-98094-2_14
https://doi.org/10.1007/978-0-387-98094-2_14